These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 799958)

  • 1. Antihypertensive effects, plasma levels and beta-adrenergi blocking activity of racemic and dextrorotatory propranolol in man.
    Rahn KH; Hawlina A; Kersting F; Planz G
    Contrib Nephrol; 1976; 3():167-70. PubMed ID: 799958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between adrenergic blocking and antihypertensive effects of beta receptor antagonists.
    Rahn KH
    Adv Clin Pharmacol; 1976; 11():14-8. PubMed ID: 25567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adrenergic neurone blockade in the hypotensive action of propranolol.
    Eliash S; Weinstock M
    Br J Pharmacol; 1971 Oct; 43(2):287-94. PubMed ID: 4400571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
    Waal-Manning HJ
    N Z Med J; 1976 Apr; 83(561):223-6. PubMed ID: 8748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intracisternal application of 6-hydroxydopamine on the antihypertensive action of propranolol in the dog.
    Montastruc JL; Montastruc P
    Eur J Pharmacol; 1980 May; 63(2-3):103-16. PubMed ID: 6247163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of drug concentration measurements in studies of the therapeutic response to propranolol.
    Chidsey C; Pine M; Favrot L; Smith S; Leonetti G; Morselli P; Zanchetti A
    Postgrad Med J; 1976; 52 Suppl 4():26-32. PubMed ID: 967771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of propranolol pharmacokinetics to antihypertensive effect and beta-adrenergic blockade in the treatment of hypertension.
    Krediet RT; Dunning AJ; Offerhaus L
    Eur J Clin Pharmacol; 1980 Nov; 18(5):391-4. PubMed ID: 6108222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of dextro-, laevo- and racemic propranolol in man.
    George CF; Fenyvesi T; Conolly ME; Dollery CT
    Eur J Clin Pharmacol; 1972 Mar; 4(2):74-6. PubMed ID: 4655684
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemodynamic effects of the optical isomers of beta-receptor blocking agents.
    Rahn KH
    Eur Heart J; 1983 Jul; 4 Suppl D():27-30. PubMed ID: 6617697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective and non-selective beta-blockade in renin release.
    Lammintausta R; Syvälahti E; Iisalo E; Kanto J; Mäntylä R
    Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):489-96. PubMed ID: 202141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the antihypertensive effect of propranolol and practolol combined with chlorthalidone.
    Geyskes GG; Stutterheim A; Boer P; Mees EJ
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):85-90. PubMed ID: 786689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic analyses of antihypertensive drugs, nifedipine and propranolol, in spontaneously hypertensive rats to investigate characteristics of effect and side effects.
    Kiriyama A; Honbo A; Nishimura A; Shibata N; Iga K
    Regul Toxicol Pharmacol; 2016 Apr; 76():21-9. PubMed ID: 26773344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiologic and pharmacokinetic determinants of the antihypertensive response to propranolol.
    Esler M; Zweifler A; Randall O; DeQuattro V
    Clin Pharmacol Ther; 1977 Sep; 22(3):299-308. PubMed ID: 330078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of renin in the antihypertensive action of beta-adrenoreceptor blocking agents.
    Stokes GS; Graham RM; Weber MA
    Drugs; 1976; 11 SUPPL 1():150-6. PubMed ID: 6247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular actions of optical isomers of propranolol.
    Yamamoto J; Sekiya A; Maekawa H; Kato Y
    Jpn J Pharmacol; 1978 Aug; 28(4):627-31. PubMed ID: 32418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central hypotensive effect of propranolol.
    Dollery CT; Lewis PJ
    Postgrad Med J; 1976; 52 Suppl 4():116-20. PubMed ID: 787951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension.
    Zweifler A; Esler M
    Am J Cardiol; 1977 Jul; 40(1):105-9. PubMed ID: 879001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of d- and l-propranolol in human plasma by high-performance liquid chromatography.
    Hermansson J; von Bahr C
    J Chromatogr; 1980 Nov; 221(1):109-17. PubMed ID: 7451612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of propranolol on development and maintanance of severe renal hypertension in rats.
    Leenen FH; Ackerman EW
    Clin Exp Pharmacol Physiol; 1976; 3(6):575-86. PubMed ID: 1009694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.